-
1.
公开(公告)号:WO0111345A3
公开(公告)日:2002-03-28
申请号:PCT/US0021758
申请日:2000-08-09
Applicant: ABBOTT LAB
Inventor: OLSON JEFFREY A , JONES RONALD B , NIENABER VICKI L , MUCHMORE STEVEN W , PAN JEFFREY Y , GREER JONATHAN
IPC: G01N23/207 , G01N23/20 , G01N35/00
CPC classification number: G01N23/20 , Y10T436/25
Abstract: Method and apparatus for mounting a sample comprising a crystal for X-ray crystallographic analysis, a method for aligning a sample comprising a crystal for X-ray crystallographic analysis, which sample is mounted on a positioning device, and a method for determining the structure of a sample containing a crystal by means of X-ray crystallography.
Abstract translation: 用于安装包括用于X射线晶体学分析的晶体的样品的方法和装置,用于将包含用于X射线晶体学分析的晶体的样品对准的方法,该样品安装在定位装置上,以及用于确定 通过X射线晶体学包含晶体的样品。
-
公开(公告)号:WO0128979A3
公开(公告)日:2001-12-27
申请号:PCT/US0027938
申请日:2000-10-10
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GIRANDA VINCENT L , KEMPF DALE J , STOLL VINCENT S , SUN MINGHUA , ZHAO CHEN , GU YU GUI , WANG GARY T , KRUEGER ALLAN C , CHEN YUANWEI , DEGOEY DAVID A , GRAMPOVNIK DAVID J , KATI WARREN M , KENNEDY APRIL L , LIN ZHEN , MADIGAN DONALD L , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , WANG SHELDON , YEUNG MING C
IPC: A61K31/195 , C07C233/48 , C07C237/24 , C07C271/22 , C07C271/24 , C07C279/16 , C07D233/54 , C07D263/32 , C07D307/24 , C07D317/30 , C07D405/04 , A61K31/325 , A61K31/34 , A61K31/415 , A61K31/42 , A61P31/00
CPC classification number: C07D233/64 , C07B2200/07 , C07B2200/09 , C07C233/48 , C07C237/24 , C07C271/22 , C07C271/24 , C07C279/16 , C07C2601/08 , C07C2601/10 , C07D263/32 , C07D307/24 , C07D317/30 , C07D405/04
Abstract: Disclosed are compounds of formula (I), (II) or (III) which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Abstract translation: 公开了可用于抑制致病微生物,特别是流感神经氨酸酶的神经氨酸酶的式(I),(II)或(III)的化合物。 还公开了用于预防和治疗由具有神经氨酸酶的微生物引起的疾病的组合物和方法,用于制备这些方法中使用的化合物和合成中间体的方法。
-
公开(公告)号:NO20005301L
公开(公告)日:2000-12-08
申请号:NO20005301
申请日:2000-10-20
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40
-
公开(公告)号:PL343678A1
公开(公告)日:2001-08-27
申请号:PL34367899
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40 , C07D407/04
-
公开(公告)号:BG104962A
公开(公告)日:2001-07-31
申请号:BG10496200
申请日:2000-11-17
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YCANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40 , C07D407/04
Abstract: Disclosed are compounds of formula which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminodase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes. 56 claims
-
公开(公告)号:CA2329422A1
公开(公告)日:1999-10-28
申请号:CA2329422
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: MADIGAN DAROLD L , LIN ZHEN , KRUEGER ALLAN C , MARING CLARENCE J , DEGOEY DAVID A , XU YIBO , YEUNG MING C , FLOSI WILLIAM J , ZHAO CHEN , KENNEDY APRIL , MUCHMORE STEVEN W , STEWART KENT D , KEMPF DALE J , SHAM HING L , GRAMPOVNIK DAVID J , STOLL VINCENT S , KATI WARREN M , WANG GARY T , GU YU-GUI , SUN MINGHUA , WANG SHELDON , MCDANIEL KEITH F , GIRANDA VINCENT L , KLEIN LARRY L , CHEN YUANWEI , CHEN HUI-JU
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40 , C07D407/04
Abstract: Disclosed are compounds of formula (I) which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
-
公开(公告)号:BR0010555A
公开(公告)日:2003-09-23
申请号:BR0010555
申请日:2000-10-10
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GIRANDA VINCENT L , KEMPF DALE J , STOLL VINCENT S , SUN MINGHUA , ZHAO CHEN , GU YU GUI , HANESSIAN STEPHEN , WANG GARY T , KRUEGER ALLAN C , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , KATI WARREN M , KENNEDY APRIL L , KLEIN LARRY L , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , TU NOAH P , WAGENAAR FRANK L , WANG SHELDON , WIEDEMAN PAUL E , XU YIBO , YEUNG MING C , BAYRAKDARIAN MALKEN , LUO XUEHONG
IPC: C07D401/12 , A61K31/357 , A61K31/40 , A61K31/401 , A61K31/4025 , A61K31/405 , A61K31/415 , A61K31/4155 , A61K31/4178 , A61K31/42 , A61K31/422 , A61K31/425 , A61K31/427 , A61K31/4439 , A61K31/5377 , A61K31/66 , A61K31/662 , A61P31/00 , A61P31/12 , A61P31/16 , A61P43/00 , C07D20060101 , C07D207/00 , C07D207/12 , C07D207/16 , C07D207/26 , C07D207/32 , C07D207/327 , C07D207/38 , C07D207/46 , C07D303/16 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D407/06 , C07D407/12 , C07D409/06 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/40 , C07F9/572
-
公开(公告)号:ZA200005238B
公开(公告)日:2001-12-04
申请号:ZA200005238
申请日:2000-09-28
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , C07D , A61K
-
公开(公告)号:TR200003065T2
公开(公告)日:2001-02-21
申请号:TR200003065
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLAIM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG GARY T , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40
-
公开(公告)号:CO5271741A1
公开(公告)日:2003-04-30
申请号:CO00079304
申请日:2000-10-18
Applicant: ABBOTT LAB
Inventor: MARRING CLARENCE J , GIRANDA VINCENT L , WARREN M KATI , KRUEGER ALLAN C , MUCHMORE STEVEN W , STOLL VINCENT S , SHELDON WANG , YUANWEI CHEN , GRAMPOVNIK DAVID J , KEMPF DALE J , ZHEN LIN , MINGHUA SUN , MING C YEUNG , DEGOEY DAVID A , YU GUI GU , APRIL L KENNEDY , MADIGAN DONALD L , KENT D STEWART , WANG GARY T , CHEN ZHAO
IPC: A61K31/16 , A61K31/18 , A61K31/195 , A61K31/341 , A61K31/381 , C07C233/48 , C07C237/24 , C07C271/22 , C07C271/24 , C07C279/16 , C07D233/54 , C07D263/32 , C07D307/24 , C07D317/30 , C07D405/04
Abstract: Un compuesto enantioméricamente enriquecido CARACTERIZADO PORQUE tiene la estereoquímica absoluta de fórmula o una sal, éster o una prodroga de los mismos,donde R1 se selecciona del grupo formado por(a) -CO2H, (b) -CH2CO2H, (c) -SO3H, (d) -CH2SO3H, (e) -SO2H, (f) -CH2SO2H, (g)-PO3H2, (h) -CH2PO3H2, (i) -PO2H, (j) -CH2PO2H, (k) tetrazolilo, (l) -CH2-tetrazolilo, (m) -C(=O)-NH-S(O)2-R11, (n) -CH2C(=O)-NH-S(O)2-R11, (o) -SO2N(T-R11)R12 y (p) -CH2SO2N(T-R11 )R12donde T se selecciona del grupo formado por(i) un enlace, (ii) -C(=O)-, (iii) -C(=O)O-, (iv) -C(=O)S-, (v) -C(O)NR36, (vi) -C(=S)O-, (vii) -C(=S)S- y (viii) -C(=S)NR36-,R11 se selecciona del grupo formado por(i) C1-C12-alquilo, (ii) C2-C12-alquenilo, (iii) cicloalquilo, (iv) (cicloalquil)alquilo, (v) (cicloalquil)alquenilo, (vi) cicloalquenilo, (vii) (cicloalquenil)alquilo, (viii) (cicloalquenil)alquenilo, (ix) arilo, (x) (aril)alquilo, (xi) (aril)alquenilo, (xii) heterocíclico, (xiii) alquilo(heterocíclico) y (xiii) (xiv) alquenilo(heterocíclico); yR12 y R36 se seleccionan, independientemente entre sí, del grupo formado por - 2 -(i) hidrógeno, (ii) C1-C12-alquilo, (iii) C2-C12-alquenilo, (iv) cicloalquilo, (v) (cicloalquil)alquilo, (vi) (cicloalquil)alquenilo, (vii) cicloalquenilo, (viii) (cicloalquenil)alquilo, (ix) (cicloalquenil)alquenilo, (x) arilo, (xi) (aril)alquilo, (xii) (aril )alquenilo, (xiii) heterocíclico, (xiv) alquilo(heterocíclico) y (xv) alquenilo(heterocíclico);X se selecciona del grupo formado por(a) -C(=O)-N(R*)-, (b) -N(R*)-C(=O)-, (c) -C(=S)-N(R*)-, (d) -N(R*)-C(=S)-, (e) -N(R*)-SO2-, y M -SO2-N(R*)-, donde R* es hidrógeno, C1-C3-alquilo inferior o ciclopropilo;R2 se selecciona del grupo formado por(a) hidrógeno, (b) C1-C6-alquilo, (C) C2-C6-alquenilo, (d) C3-C6-cicloalquilo, (e) C5-C6-cicloalquenilo, (f) halo-C1-C6-alquilo y (g) halo-C2-C6-alquenilo;o R2-X es donde Y1 es -CH2-, -O-, -S- o -NH- e Y2 es -C(=O)- o -C(Raa)(Rbb), donde Raa y Rbb se seleccionan, independientemente entre sí, del grupo formado por hidrógeno, C1-C3-alquilo inferior, hidroximetilo, 1-hidroxietilo, 2-hidroxietilo, aminometilo, 1-aminoetilo, 2-aminoetilo, tiolmetilo, 1-tioletilo, 2-tioletilo, metoximetilo, N-metilaminometilo y metiltiometilo;Z1 es -O-, -S-, or C(R5)2;R3 y R4 se seleccionan, independientemente entre sí, del grupo formado por (a) hidrógeno, (b) cicloalquilo, (c) cicloalquenilo, (d) heterocíclico, (e) arilo y (f) -Z-R14donde Z es(i) -C(R37a)(R37b)-, (ii) -C(R47)=C(R48)-, (iii) -C=C-, (iv) -C(=O)- (v) -C(=S)-, (vi) -C(=NR15)-, (vii) -C(R37a)-C(OR37c)-, (viii) -C(R37a)(SR37c)-, (ix)-C(R37a)(N(R37b)(R37c))-, (x) -C(R37a)(R37b)-O-, (xi)-C(R37a)(R37b)-N(R37c)-, (xii) -C(R37a)(R37b)-N(O)(R37c), (xiii) -C(R37a)(R37b)-N(OH)-, (xiv) -C(R37a)(R37b)-S-, (xv) -C(R37a)(R37b)-S(O)-, (xvi) -C(R37a)(R37b)-S(O)2-, (xvii) -C(R37a)(R37b)-C(=O)-, (xviii) -C(R37a)(R37b)-C(=S)-, (xix) -C(R37a)(R37b)-C(=NR15)-, (xx) -C(R37a)(OR37c)-C(=O)-, (xxi) -C(R37a)(SR37b)-C(=O)-, (xxii) -C(R37a)(OR37c)-C(=S)-, (xxiii) -C(R37a)(SR37c)-C(=S)-, (xxiv) -C(=O)-C(R37a)(OR37c)-, (xxv) -C(=O)-C(R37a)(SR37c)-, (xxvi) -C(=S)-C(R37a)(OR37c)-, (xxvii)-C(=S)-C(R37a)(SR37c)-, (xxviii) -C(R37a)(OR37c)-C(R37a)(OR37c)-, (xxix) -C(R37a)(SR37c)-C(R37a)(OR37c)-, (xxx) -C(R37a)(OR37c)-C(R37a)(SR37c)-, (xxxi) -C(R37a)(SR37c)-C(R37a)(SR37c)-, (xxxii) -C(=O)-C(=O)-, (xxxiii) -C(=S)-C(=S)-, (xxxiv)-C(=O)-O-, (xxxv) -C(=O)-S-, (xxxvi) -C(=S)-O-, (xxxvii) -C(=S)-S-, (xxxviii) -C(=O)-N(R37a)- (xxxix) -C(=S)-N(R37a)-, (xl)-C(R37a)(R37b)-C(=O)-N(R37a)-, (xli) -C(R37a)(R37b)-C(=S)-N(R37a)-, (xlii) -C(R37a)(R37b)-C(=O)-O-, (xliii) -C(R37a)(R37b)-C(=O)-S-, (xliv) -C(R37a)(R37b)-C(=S)-O-, (xlv) -C(R37a)(R37b)-C(=S)-S-, (xlvi)-C(R37a)(R37b)-N(R37b)-C(=O)-, (xlvii) -C(R37a)(R37b)-N(R37b)-C(=S)-, (xlviii)-C(R37a)(R37b)-O-C(=O)-, (xlix) -C(R37a)(R37b)-S-C(=O)-, (I) -C(R37a)(R37b)-O-C(=S)-, (li) -C(R37a)(R37b)-S-C(=S)-, (lii) -C(R37a)(R37b)-N(R37b)-C(=O)-N(R37a) (liii) -C(R37a)(R37b)-N(R37b)-C(=S)-N(R37a)-, (liv) -C(R37a)(R37b)-N(R37b)-C(=O)-O-, (lv) -C(R37a)(R37b)-N(R37b)-C(=O)-S-, (lvi) -C(R37a)(R37b)-N(R37b)-C(=S)-O- (lvii) -C(R37a)(R37b)-N(R37b)-C(=S)-S-, (lviii) -C(R37a)(R37b)-O-C(=O)-N(R37a)-, (lix) -C(R37a)(R37b)-S-C(=O)-N(R37a), (Ix) -C(R37a)(R37b)-O-C(=S)-N(R37a)-, (lxi) -C(R37a)(R37b)-S-C(=S)-N(R37a), (lxii) -C(R37a)(R37b)-O-C(=O)-O-, (lxiii) -C(R37a)(R37b)-S-C(=O)-O, (lxiv) -C(R37a)(R37b)-O-C(=O)-S-, (lxv) -C(R37a)(R37b)-S-C(=O)-S-, (lxvi) -C(R37a)(R37b)-O-C(=S)-O-, (lxvii) -C(R37a)(R37b)-S-C(=S)-O-, (lxviii) -C(R37a)(R37b)-O-C(=S)-S-, (lxix) -C(R37a)(R37b)-S-C(=S)-S-, o (lxx) -C(R37a)(R37b)-C(R37a)(OR37c);R14 es(i) hidrógeno, (ii) C1-C12-alquilo, (iii) haloalquilo, (iv) hidroxialquilo, (v) alquilotiol-sustituido, (vi) alquilo R37c-O-sustituido, (vii) alquilo R37c-S-sustituido, (viii) aminoalquilo, (ix) alquilo (R37c)NH-sustituido, (x) alquilo(R37a)(R37c)N-sustituido, (xi) alquilo R37a -O-(O=)C-sustituido, (xii) alquilo R37a-S-(O=)C-sustituido, (xiii) alquiloR37aO-(S=)C-sustituido, (xiv) alquilo R37a-S-(S=)C-sustituido, (xv) alquilo (R37aO)2-P(=O)-sustituido, (xvi) cianoalquilo, (xvi) C2-C12-alquenilo, (xviii) haloalquenilo, (xix) C2-C12-alquinilo,(xx) cicloalquilo, (xxi) (cicloalquil)alquilo, (xxii) (cicloalquil)alquenilo, (xxiii) (cicloalquil)alquinilo, (xxiv) cicloalquenilo, (xxv) (cicloalquenil)alquilo, (xxvi) (cicloalquenil)alquenilo, (xxvii) (cicloalquenil)alquinilo, (xxviii) arilo, (xxix) (aril)alquilo, (xxx) (aril)alquenilo, (xxxi) (aril)alquinilo, (xxxii) heterocíclico, (xxxiii) alquil(heterocíclico), (xxxiv) alquenil(heterocíclico) o (xxxv) alquinil(heterocíclico),con la condición que es distinto de hidrógeno cuando Z es-C(R37a)(R37b)-N(R37b)-C(=O)-O-, -C(R37a)(R37b)-N(R37b)-C(=S)-O-, -C(R37a)(R37b)-N(R37b)-C(=O)-O-, -C(R37a)(R37b)-N(R37b)-C(=S)-S-, - 3 --C(R37a)(R37b)-O-C(=O)-O-, -C(R37a)(R37b)-O-C(=S)-O-, -C(R37a)(R37b)-S-C(=O)-O-, -C(R37a)(R37b)-S-C(=S)-O-, -C(R37a)(R37b)-O-C(=O)-S-, -C(R37a)(R37b)-O-C(=S)-S-, -C(R37a)(R37b)-S-C(=O)-S o -C(R37a)(R37b)-S-C(=S)-S-; R37a, R37b y R37c, se seleccionan en cada aparición, independientemente entre sí, del grupo formado por(i) hidrógeno, (ii) C1-C12-alquilo, (iii) haloalquilo, (iv) hidroxialquilo, (v) alcoxialquilo, (vi) C2-C12-alquenilo, (vii) haloalquenilo, (viii) C2-C12-alquinilo, (ix) cicloalquilo, (x)(cicloalquil)alquilo, (xi) (cicloalquil)alquenilo, (xii) (cicloalquil)alquinilo, (xiii) cicloalquenilo, (xiv) (cicloalquenil)alquilo, (xv) (cicloalquenil)alquenilo, (xvi) (cicloalquenil)alquinilo, (xvii) arilo, (xviii) (aril)alquilo, (xix) (aril)alquenilo, (xx) (aril)alquinilo, (xxi) heterocíclico, (xxii) alquil(heterocíclico), (xxiii) alquenil(heterocíclico) y (xxiv) alquinil(heterocíclico),R37c se selecciona en cada aparición, independientemente, del grupo formado por: (i) hidrógeno, (ii) C1-C12-alquilo, (iii) haloalquilo, (iv) C2-C12-alquenilo, (v) haloalquenilo, (vi) C2-C12-alquinilo, (vii) cicloalquilo, (viii) (cicloalquil)alquilo, (ix) (cicloalquil)alquenilo, (x) (cicloalquil)alquinilo, (xi) cicloalquenilo, (xii) (cicloalquenil)alquilo, (xiii) (cicloalquenil)alquenilo, (xiv) (cicloalquenil)alquinilo, (xv) arilo, (xvi) (aril)alquilo, (xvii) (aril)alquenilo, (xviii) (aril)alquinilo, (xix) heterocíclico, (xx) alquilo(heterocíclico), (xxi) alquenilo(heterocíclico) (xxii) alquinilo(heterocíclico), (xxiii) -C(=O)-R14, y (xxiv) -C(=S)-R, (xxv) -S(O)2-R14 y (xxvi) hidroxialquilo;o cuando Z es -C(R37a)(R37b)-N(R37c)-, entonces cuando N(R37C)-R14 se toman juntos constituyen un grupo azida;o cuando Z es -C(R37a)(R37b)-N(O)(R37c)-, entonces cuando N(O)(R37C)-R14 se toman juntos constituyen un anillo heterocíclico de 3-7 miembros N-oxidado que posee por lo menos un átomo de nitrógeno en el anillo N-oxidado,o cuando Z es -C(R37a)(OR37c)-, -C(R37a)(SR37c)- o - -C(R37a)(N(R37b)(R37c))-, luego R37a, R14 y el átomo de carbono al que estaban unidos cuando se toman juntos forman un anillo ciclopentilo, ciclopentenilo, ciclohexilo o ciclohexenilo o luego OR37c o SR37c o N(R37c) y R14 y el átomo de carbono al que están unidos cuando se toman juntos forman un anillo heterocíclico que contiene un átomo de O, S o N, respectivamente, y conteniendo desde 4 a 8 átomos del anillo;R15 se selecciona del grupo formado por(i) hidrógeno, (ii) hidroxi, (iii) amino, (iv) C1-C12-alquilo, (v) haloalquilo, (vi) C2-C12-alquenilo, (vii) haloalquenilo, (viii) cicloalquilo, (ix) (cicloalquil)alquilo, (x) (cicloalquil)alquenilo, (xi) cicloalquenilo, (xii) (cicloalquenil)alquilo, (xiii) (cicloalquenil)alquenilo, (xiv) arilo, (xv) (aril)alquilo, (xvi) (aril)alquenilo, (xvii) heterocíclico, (xviii) alquilo(heterocíclico) y (xix) alquenilo(heterocíclico),o R3 y R4 tomados juntos, con el átomo al cual están unidos, forman un anillo carbocíclico o heterocíclico que posee de 3 a 8 átomos en el anillo;R5 en cada aparición, se selecciona independientemente del grupo formado por:(a) hidrógeno, (b) -CH(R38)2, (c) -(CH2)r-O-R40, (d) C2-C4 alquinilo, (e) ciclopropilo, (f) ciclobutilo, (g) -C(=Q1)-R17, y (h) -(CH2)rN(R19)2donde r es 0, 1 ó 2; con la condición que cuando un R5 es -O-R40 o -N(R19)2, entonces el otro R5 es diferente que -O-R40 o -N(R19)2; donde Q1 es O, S o N(R18);R17 y R18 se seleccionan independientemente, en cada aparición, del grupo formado por hidrógeno, metilo y etilo;R19 , R38 y R40 se seleccionan independientemente, en cada aparición, del grupo formado por(i) hidrógeno, (ii) C1-C12-alquilo, (iii) haloalquilo, (iv) C2-C12-alquenilo, (v) haloalquenilo, (vi) cicloalquilo, (vii) (cicloalquil)alquilo, (viii) (cicloalquil)alquenilo, (ix) cicloalquenilo, (x) (cicloalquenil)alquilo, (xi) (cicloalquenil)alquenilo, (xii) arilo, (xiii) (aril)alquilo, (xiv) (aril)alquenilo, (xv) heterocíclico, (xvi) alquilo(heterocíclico) y (xvii) alquenilo(heterocíclico); o un R19 es un grupo N-protector;o los dos grupos R5 se toman juntos con un átomo de carbono al cual están unidos, forman un anillo carbocíclico o heterocíclico q
-
-
-
-
-
-
-
-
-